isopropyl-thiogalactoside has been researched along with Cell-Transformation--Neoplastic* in 8 studies
8 other study(ies) available for isopropyl-thiogalactoside and Cell-Transformation--Neoplastic
Article | Year |
---|---|
Roles of phosphatidylinositol 3'-kinase and mammalian target of rapamycin/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial cells.
Phosphatidylinositol 3'-kinase (PI3K) activity is required for Ras- mediated transformation of intestinal epithelial cells (IECs). The mammalian target of rapamycin (mTOR) and its downstream pathways control the translation of specific mRNAs that are required for cell proliferation and transformation. Here, we elucidated the roles of PI3K and mTOR in K-Ras-mediated transformation of IECs (IEC-6). Induction of K-Ras activated PI3K and mTOR in IECs. p70 ribosomal protein S6 kinase activity was induced by K-Ras in a PI3K- and mTOR-dependent manner. K-Ras did not significantly alter the phosphorylation of eukaryotic initiation factor 4E-binding protein 1. Treatment with either LY-294002 or rapamycin inhibited IEC proliferation and resulted in G(1) growth arrest. However, it was noted that inhibition of mTOR enhanced K-Ras-mediated morphological transformation and increased invasiveness of IECs in a mitogen-activated protein/extracellular signal-regulated kinase-dependent manner. Furthermore, inhibition of PI3K or mTOR impaired the growth of an array of colon cancer cells. Spindle transformation, reduced E-cadherin, and increased invasiveness were observed in LY-294002-treated Moser cells. Thus, our results suggest that K-Ras-mediated transformation of IECs involves activation of the PI3K/mTOR pathway. Inhibition of PI3K/mTOR activity leads to G(1) growth arrest of transformed IECs. On the other hand, inhibition of PI3K or mTOR may induce the epithelial to mesenchymal transdifferentiation of IECs under certain circumstances. Topics: Cell Differentiation; Cell Division; Cell Line; Cell Transformation, Neoplastic; Colonic Neoplasms; Enzyme Activation; Enzyme Inhibitors; Genes, ras; Humans; Intestinal Mucosa; Isopropyl Thiogalactoside; Kinetics; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Protein Kinases; Rectal Neoplasms; Ribosomal Protein S6 Kinases; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; TOR Serine-Threonine Kinases; Transcription, Genetic | 2004 |
Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4.
The loss of growth-inhibitory responses to transforming growth factor-beta (TGF-beta) is a frequent consequence of malignant transformation. Smad2, Smad3, and Smad4 proteins are important mediators of the antiproliferative responses to TGF-beta and may become inactivated in some human cancers. Epithelial cells harboring oncogenic Ras mutations often exhibit a loss of TGF-beta antiproliferative responses. To further investigate the effect of oncogenic Ras in TGF-beta signaling, we used an isopropyl-1-thio-beta-d-galactopyranoside-inducible expression system to express Ha-Ras(Val-12) in intestinal epithelial cells. Induction of Ha-Ras(Val-12) caused a decrease in the level of Smad4 expression, inhibited TGF-beta-induced complex formation between Smad2/Smad3 and Smad4, blocked Smad4 nuclear translocation, inhibited the TGF-beta-mediated decrease in [(3)H]thymidine incorporation, and repressed TGF-beta-activated transcriptional responses. The withdrawal of isopropyl-1-thio-beta-d-galactopyranoside or the addition of an inhibitor of the ubiquitin-proteasome pathway restored the Smad4 level and TGF-beta-induced Smad complex formation. Forced expression of Smad4 resulted in partial recovery of the TGF-beta-mediated growth inhibition and transcriptional responses in the presence of oncogenic Ras. Further, PD98059, a specific inhibitor of the MEK/ERK/mitogen-activated protein kinase pathway prevented the Ras-induced decrease in Smad4 expression and complex formation. Our results suggest a novel mechanism by which oncogenic Ras represses TGF-beta signaling by mitogen-activated protein kinase-dependent down-regulation of Smad4, thereby subverting the tumor suppressor function of TGF-beta. Topics: Animals; Cell Division; Cell Line, Transformed; Cell Nucleus; Cell Transformation, Neoplastic; DNA-Binding Proteins; Gene Expression Regulation; Genes, ras; Genes, Tumor Suppressor; Isopropyl Thiogalactoside; Kinetics; Mutation; Protein Transport; Signal Transduction; Thymidine; Trans-Activators; Transcription, Genetic; Transforming Growth Factor beta | 2001 |
Oncogenic transformation increases the sensitivity for apoptosis induction by inhibitors of macromolecular synthesis.
Inhibition of RNA or protein synthesis causes apoptosis in fibroblasts. This points to the constitutive expression of a long-lived apoptosis machinery which is controlled by shortlived negative regulatory proteins, termed endogenous survival factors. The length of time between addition of the inhibitor of macromolecular synthesis and the onset of apoptosis can be used as an estimation of the effective survival factor concentration. Transformation of rat fibroblasts by a constitutively expressed src oncogene or an inducible ras oncogene increases the sensitivity for apoptosis induction by inhibitors of macromolecular synthesis, indicating that their endogenous survival factor pool has been decreased. Topics: Animals; Apoptosis; Buthionine Sulfoximine; Cell Line, Transformed; Cell Membrane; Cell Survival; Cell Transformation, Neoplastic; Chromatin; Cycloheximide; Fibroblasts; Genes, ras; Genes, src; In Situ Nick-End Labeling; Isopropyl Thiogalactoside; Kinetics; Protein Synthesis Inhibitors; Rats; Reactive Oxygen Species; Transforming Growth Factor alpha | 2000 |
Cellular Ras partly mediates gap junction closure by the polyoma virus middle tumor antigen.
Endogenous, cellular Ras proteins (c-Ras) mediate the transforming action of the polyoma virus middle Tumor antigen (mT), which is accompanied by elimination of gap junctional, intercellular communication (GJIC). In this report we show that reducing the c-Ras content of murine C3H10T1/2 fibroblasts (10T1/2) through the expression of an anti-sense ras gene, increased GJIC by 60-80% mT totally eliminated GJIC in normal 10T1/2 cells but it reduced GJIC no more than 50% in the c-Ras deficient lines. These results indicate that endogenous c-Ras is at least partly responsible for the mT-induced gap junction closure. Topics: Animals; Antigens, Polyomavirus Transforming; Cell Communication; Cell Line; Cell Transformation, Neoplastic; Dexamethasone; Electric Stimulation; Electroporation; Gap Junctions; Genes, ras; Isopropyl Thiogalactoside; Mice; Proto-Oncogene Proteins p21(ras); RNA, Antisense; Zinc | 1996 |
Mitotic and post mitotic consequences of genomic instability induced by oncogenic Ha-ras.
Induced expression of a mutant human Ha-ras oncogene in NIH3T3 cells leads to the rapid production of multicentric chromosomes, acentric chromosome fragments, double minute chromosomes, increased heteroploidy, and increased capacity to undergo gene amplification. In this study we have used fluorescent-in-situ hybridization (FISH) to demonstrate that induction of the Ha-ras oncogene also leads to disruption of the mitotic machinery, resulting in aberrant mitoses and abnormal daughter cells. Cells induced to express an oncogenic Ha-ras transgene accumulate chromosomes that lag outside of the rest of the chromosomal architecture, chromosomes that form bridges between daughter nuclei at anaphase, and that form micronuclei. Many of these mitotic aberrations contain structurally abnormal chromosomes. These ras-induced changes were suppressed by the introduction of a gene encoding the dominant negative effector of ras, raf 301. Expression of raf301 in cells induced to express Ha-ras reduced the level of growth in soft agar, chromosome aberrations, mitotic aberrations, and frequency of gene amplification. These data provide evidence for an association between Ha-ras induced transformation, chromosome aberrations and gene amplification. Furthermore they offer insight into how the cell responds to the formation of aberrant chromosomes, and how disrupting chromosomal architecture could lead to further imbalances in the distribution of genetic material between daughter cells. Topics: 3T3 Cells; Adenine; Animals; Cell Cycle; Cell Survival; Cell Transformation, Neoplastic; Chromosome Aberrations; Drug Interactions; Enzyme Inhibitors; Gene Expression; Genes, ras; Humans; In Situ Hybridization, Fluorescence; Isopropyl Thiogalactoside; Mice; Mitosis; Polyploidy; Protein-Tyrosine Kinases; Proto-Oncogene Proteins p21(ras); Transfection | 1995 |
Use of lac activator proteins for regulated expression of oncogenes.
Topics: 3T3 Cells; Actins; Animals; Cell Line; Cell Transformation, Neoplastic; Chloramphenicol O-Acetyltransferase; Cloning, Molecular; Gene Expression Regulation; Genes, p53; Genetic Vectors; HeLa Cells; Humans; Isopropyl Thiogalactoside; L Cells; Mice; Oncogenes; Promoter Regions, Genetic; Rats; Recombinant Proteins; Repressor Proteins; Trans-Activators; Transfection | 1995 |
Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
Oncogene activation and loss of tumor suppressor genes are known to play a role in tumor initiation as well as its progression. The potential roles of these genes in perturbation of genome stability has become a major interest. To better understand the relationship between expression of an oncogene and genetic instability, we have studied a cell line expressing an activated human Ha-ras under the control of bacterial lactose operon regulatory elements for changes in methotrexate resistance and dihydrofolate reductase (dhfr) gene amplification following mutant Ha-ras induction. In these cells mutant Ha-ras is directed by an inducible SV40 promoter containing a bacterial lac operator sequence which is repressed due to constitutive expression of bacterial lac repressor gene. The expression of this Ha-ras is specifically induced by the addition of isopropyl-1-thio-beta-D-galactopyranoside (IPTG), a lactose analogue, to the culture medium. During single-step methotrexate selection, these cells showed an increased frequency of methotrexate resistance in the presence of IPTG. More than 60% of the methotrexate-resistant colonies showed a 2-6-fold amplification of the dhfr gene. One clone with rearranged dhfr had about 100-fold amplification of the gene. The increased capacity to amplify DNA in response to mutant Ha-ras induction was not locus specific since cells also displayed an increased frequency of resistance to N-(phosphonacetyl)-L-aspartic acid in the presence of ITPG. Four of the methotrexate-resistant clones with amplified dhfr gene were cultured further in the presence or absence of IPTG and subsequently compared for their ability to grow in soft agar as a measure of transformation. In medium containing methotrexate but no IPTG, the clones were unable to grow in soft agar, indicating that methotrexate resistance due to gene amplification is separable from transformation. Topics: 3T3 Cells; Animals; Antineoplastic Agents; Aspartic Acid; Cell Transformation, Neoplastic; Drug Resistance; Gene Amplification; Gene Expression Regulation, Neoplastic; Genes, ras; Isopropyl Thiogalactoside; Methotrexate; Mice; Phosphonoacetic Acid; Tetrahydrofolate Dehydrogenase | 1994 |
Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle.
The proto-oncogene transcription factors Fos and Jun form a heterodimeric complex that binds to DNA and regulates expression of specific target genes. Continuous expression of c-fos causes transformation of cultured fibroblasts and induces osteogenic sarcoma in mice. To investigate the molecular basis of fos-mediated oncogenesis, we developed a conditional cell transformation system in which Fos expression was regulated by isopropyl-beta-D-thiogalactopyranoside (IPTG). Synthesis or repression of Fos in L1-3c-fos cells occurred rapidly, within 30 min, after the removal or addition of IPTG to the culture medium. However, there was a significant delay between the induction of Fos expression and the appearance of morphological transformation. No effect was observed after 12 h of Fos expression, partial transformation was detected after 24 h, and full transformation required approximately 3 days of continuous Fos expression. Similarly, the transformed cell morphology persisted for at least 2 days after repression of Fos, and a normal phenotype was observed only after 3 days. Fos-Jun complexes, capable of binding to AP-1 sequences, were present continuously during the delay in morphological transformation. Furthermore, increased expression of several candidate Fos target genes, including those encoding Fra-1, transin (stromelysin), collagenase, and ornithine decarboxylase, was detected shortly after Fos induction. The induction of morphological transformation was not dependent on the cell cycle, as it occurred in both cycling and noncycling cells. Thus, the Fos-Jun complexes present before L1-3c-fos cells become fully transformed are transcriptionally active. These complexes disappeared, and the Fos target genes were repressed at least 2 days prior to reversion. Our results suggest that cell transformation by Fos requires increased expression of a target gene(s) with a long-lived product(s) that must reach a critical level. Topics: Animals; Bone Neoplasms; Cell Cycle; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; DNA-Binding Proteins; Fibroblasts; Gene Expression; Genes, fos; Isopropyl Thiogalactoside; Kinetics; Mice; Osteosarcoma; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Restriction Mapping; Time Factors; Transfection | 1994 |